{
    "clinical_study": {
        "@rank": "164731", 
        "arm_group": [
            {
                "arm_group_label": "placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "placebo"
            }, 
            {
                "arm_group_label": "Modafinil", 
                "arm_group_type": "Active Comparator", 
                "description": "Modafinil"
            }
        ], 
        "brief_summary": {
            "textblock": "This study is an investigator initiated placebo controlled double blinded  trial. The\n      hypothesis is that treatment with modafinil positively will affect behavioural and cognitive\n      rehabilitation after stroke, causing the treatment group to experience decreased fatigue,\n      increased endurance, improved skills of sustaining attention and faster reaction times. The\n      cognitive rehabilitation will show in increased muscle mass, decreased osteoporosis and\n      better physical performances due to a higher level of physical activity."
        }, 
        "brief_title": "Treatment of Post Stroke Fatigue With a Wakefulness Promoting Agent", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Stroke", 
            "Post Stroke Fatigue"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Fatigue", 
                "Stroke", 
                "Cerebral Infarction"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 years of age and stroke within 14 days\n\n          -  Modified Rankin Scale 3 or under and Barthel 85 or over before stroke\n\n          -  Person that can understand instruction and do tests and questionnaires on their own\n             or with support\n\n          -  has given informed consent\n\n          -  MFI-20 score of 12 or more\n\n          -  Infertile person or fertile women tested negative of pregnancy and using safe\n             anticonception\n\n        Exclusion Criteria:\n\n          -  Dementia or other neuropsychiatric disease making the person incapable of\n             understanding instructions\n\n          -  Other disease with fatigue as a known symptom\n\n          -  stroke induced by trauma, infection or surgical procedure\n\n          -  former drug abuse\n\n          -  known contraindication to treatment with modafinil\n\n          -  known active malignancy, benign intracranial tumor, subdural or epidural bleeding\n\n          -  kidneydysfunction with creatinin more than 265 micromol/L or liver disease with ASAT\n             (aspartate aminotransferase) elevated to more than 70 U/L for women or 100 U/L for\n             men.\n\n          -  allergy to project treatment\n\n          -  use of benzodiazepin or antiepileptic drugs in a fixed dose. Sleeping pills not\n             included.\n\n          -  Patients threaded with ciclosporin or anti HIV medication"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "128", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 23, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01800097", 
            "org_study_id": "ModaA001"
        }, 
        "intervention": [
            {
                "arm_group_label": "Modafinil", 
                "description": "Tablet, 400 mg once daily, morning (200 mg if age 65 or above) for 3 months", 
                "intervention_name": "modafinil", 
                "intervention_type": "Drug", 
                "other_name": "modiodal, provigil"
            }, 
            {
                "arm_group_label": "placebo", 
                "description": "Tablets, 400 mg once daily ( 200 mg if age 65 or above)morning for 3 months.", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Modafinil"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "stroke", 
            "fatigue", 
            "modafinil"
        ], 
        "lastchanged_date": "February 25, 2013", 
        "location": {
            "contact": {
                "email": "mai.bang.poulsen@regionh.dk", 
                "last_name": "Mai Poulsen, MD", 
                "phone": "0045 38681167"
            }, 
            "contact_backup": {
                "email": "karsten.overgaard@regionh.dk", 
                "last_name": "Karsten Overgaard, MD"
            }, 
            "facility": {
                "address": {
                    "city": "Herlev", 
                    "country": "Denmark", 
                    "zip": "2730"
                }, 
                "name": "Department of Neurology, Herlev Hospital,"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "Treatment of Post Stroke Fatigue With Modafinil, Effect on Rehabilitation, Fatigue and Bonemass Index", 
        "other_outcome": [
            {
                "description": "DXA-scans. (dual energy x-ray absorptiometry)", 
                "measure": "Change in bone mineral density and musclemass from baseline to 3 months", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "A special designed computerprogramme will be used to measure the patients reactiontime.", 
                "measure": "Reactiontime", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "description": "Questionnaire", 
                "measure": "Stroke Specific Quality Of Life (SSQOL)", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "score", 
                "measure": "Change in Barthel Index", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "score", 
                "measure": "Modified Ranking Scale", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Questionnaire", 
                "measure": "Multidimensional Depression Inventory", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "Change in \"Time up and go\" and \"chair to stand test\" from baseline", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "test", 
                "measure": "Cognitive performance, Montreal Cognitive Assessment(MOCA)", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "DXA-scan", 
                "measure": "Change in bone mineral density and musclemass from baseline to 6 months", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "A special designed computerprogramme will be used to measure the patients reactiontime.", 
                "measure": "Reactiontime", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "A special designed computerprogramme will be used to measure the patients reactiontime.", 
                "measure": "Reactiontime", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Questionnaire", 
                "measure": "Stroke Specific Quality Of Life", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Change in Barthel Index", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "score", 
                "measure": "Modified Ranking Scale", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Change in \"Time up and go\" and \"chair to stand test\" from baseline", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Questionnaire", 
                "measure": "Multidimensional Depression Inventory", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "test", 
                "measure": "Cognitive performance, Montreal Cognitive Assessment(MOCA)", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Questionnaire", 
                "measure": "Stroke Specific Quality Of Life (SSQOL)", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "description": "score", 
                "measure": "Change in Barthel Index", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "description": "score", 
                "measure": "Modified Ranking Scale", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "description": "Questionnaire", 
                "measure": "Multidimensional Depression Inventory", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "measure": "Change in \"Time up and go\" and \"chair to stand test\" from baseline", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "description": "test", 
                "measure": "Cognitive performance, Montreal Cognitive Assessment(MOCA)", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }
        ], 
        "overall_official": {
            "affiliation": "Department of Neurology, Herlev Hospital", 
            "last_name": "Karsten Overgaard, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Denmark: The Danish National Committee on Biomedical Research Ethics", 
                "Denmark: Danish Health and Medicines Authority"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Questionnaire", 
            "measure": "Multidimensional Fatigue Inventory (MFI- 20)", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01800097"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Herlev Hospital", 
            "investigator_full_name": "Karsten Overgaard", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Questionnaire", 
                "measure": "MFI-20", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "description": "Questionnaire", 
                "measure": "MFI-20", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Fatigue severity scale (FSS)", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Questionnaire", 
                "measure": "FSS", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "description": "Questionnaire", 
                "measure": "FSS", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "source": "Herlev Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Herlev Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}